80
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Plasma Pentraxin-3 Combined with Plaque Characteristics Predict Cardiovascular Risk in ST-Segment Elevated Myocardial Infarction: An Optical Coherence Tomography Study

, , , , , , , ORCID Icon, , , & show all
Pages 4409-4419 | Published online: 02 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xiaoxiao Zhao, Li Song, Ying Wang, Jiannan Li, Jinying Zhou, Runzhen Chen, Chen Liu, Peng Zhou, Zhaoxue Sheng, Yi Chen, Hanjun Zhao & Hongbing Yan. (2021) Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI. Journal of Inflammation Research 14, pages 5319-5335.
Read now

Articles from other publishers (3)

Runzhen Chen, Jiannan Li, Jinying Zhou, Ying Wang, Xiaoxiao Zhao, Nan Li, Weida Liu, Chen Liu, Peng Zhou, Yi Chen, Shaodi Yan, Li Song, Hongbing Yan & Hanjun Zhao. (2023) Prognostic impacts of Lipoxin A4 in patients with acute myocardial infarction: A prospective cohort study. Pharmacological Research 187, pages 106618.
Crossref
Panagiotis Theofilis, Marios Sagris, Alexios S. Antonopoulos, Evangelos Oikonomou, Konstantinos Tsioufis & Dimitris Tousoulis. (2022) Non-Invasive Modalities in the Assessment of Vulnerable Coronary Atherosclerotic Plaques. Tomography 8:4, pages 1742-1758.
Crossref
Kejun Ding, Zhewei Shi, Caizhen Qian & Xuan Yang. (2022) Higher Plasma Pentraxin-3 Level Predicts Adverse Clinical Outcomes in Patients With Coronary Artery Disease: A Meta-Analysis of Cohort Studies. Frontiers in Cardiovascular Medicine 8.
Crossref